Fort Sheridan Advisors’s Merck MRK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $12.6M | Sell |
98,070
-541
| -0.5% | -$63.3K | 1.36% | 17 |
|
|
2026
Q1 | $11.9M | Buy |
98,611
+1,773
| +2% | +$205K | 1.43% | 15 |
|
|
2025
Q4 | $10.2M | Buy |
96,838
+3,405
| +4% | +$320K | 1.3% | 15 |
|
|
2025
Q3 | $7.84M | Sell |
93,433
-197
| -0.2% | -$16.2K | 1.03% | 19 |
|
|
2025
Q2 | $7.41M | Sell |
93,630
-1,905
| -2% | -$151K | 1.06% | 20 |
|
|
2025
Q1 | $8.58M | Sell |
95,535
-2,724
| -3% | -$254K | 1.3% | 18 |
|
|
2024
Q4 | $9.77M | Sell |
98,259
-175
| -0.2% | -$18K | 1.43% | 13 |
|
|
2024
Q3 | $11.2M | Sell |
98,434
-278
| -0.3% | -$33K | 1.7% | 12 |
|
|
2024
Q2 | $12.2M | Buy |
98,712
+7,805
| +9% | +$1.01M | 1.97% | 11 |
|
|
2024
Q1 | $12M | Buy |
90,907
+783
| +0.9% | +$96.5K | 2.26% | 10 |
|
|
2023
Q4 | $9.83M | Buy |
90,124
+2,265
| +3% | +$235K | 1.96% | 11 |
|
|
2023
Q3 | $9.05M | Buy |
87,859
+3,316
| +4% | +$357K | 2.05% | 10 |
|
|
2023
Q2 | $9.76M | Buy |
84,543
+4,177
| +5% | +$474K | 2.23% | 10 |
|
|
2023
Q1 | $8.55M | Buy |
80,366
+19,697
| +32% | +$2.13M | 2.17% | 10 |
|
|
2022
Q4 | $6.73M | Sell |
60,669
-2,897
| -5% | -$296K | 2.19% | 9 |
|
|
2022
Q3 | $5.47M | Buy |
63,566
+409
| +0.6% | +$36.5K | 1.85% | 11 |
|
|
2022
Q2 | $5.76M | Buy |
63,157
+7,751
| +14% | +$687K | 1.87% | 10 |
|
|
2022
Q1 | $4.55M | Buy |
55,406
+2,692
| +5% | +$212K | 1.33% | 14 |
|
|
2021
Q4 | $4.04M | Sell |
52,714
-1,076
| -2% | -$85.7K | 1.17% | 16 |
|
|
2021
Q3 | $4.04M | Buy |
53,790
+1,405
| +3% | +$107K | 1.32% | 14 |
|
|
2021
Q2 | $4.07M | Buy |
52,385
+6,310
| +14% | +$469K | 1.36% | 14 |
|
|
2021
Q1 | $3.39M | Buy |
46,075
+6,347
| +16% | +$468K | 1.35% | 13 |
|
|
2020
Q4 | $3.1M | Buy |
39,728
+462
| +1% | +$35.3K | 1.51% | 14 |
|
|
2020
Q3 | $3.11M | Buy |
39,266
+41
| +0.1% | +$3.21K | 1.84% | 12 |
|
|
2020
Q2 | $2.89M | Buy |
39,225
+1,260
| +3% | +$94.9K | 1.78% | 12 |
|
|
2020
Q1 | $2.79M | Buy |
37,965
+3,045
| +9% | +$239K | 2.05% | 11 |
|
|
2019
Q4 | $3.03M | Buy |
34,920
+941
| +3% | +$77.3K | 1.63% | 11 |
|
|
2019
Q3 | $2.73M | Buy |
33,979
+325
| +1% | +$26K | 1.53% | 12 |
|
|
2019
Q2 | $2.69M | Buy |
33,654
+2,410
| +8% | +$185K | 1.56% | 13 |
|
|
2019
Q1 | $2.48M | Buy |
31,244
+3,144
| +11% | +$235K | 1.62% | 13 |
|
|
2018
Q4 | $2.05M | Buy |
+28,100
| New | +$1.98M | 1.45% | 14 |
|
Other funds holding MRK
Fort Sheridan Advisors's MRK Position: Q2 2026 in Review
Fort Sheridan Advisors reduced its Merck (MRK) stake by 0.55% in Q2 2026, selling an estimated $63.3K and leaving 98,070 shares worth $12.6M. The position accounts for 1.36% of the portfolio, ranked #17.
Fort Sheridan Advisors first reported a position in MRK in Q4 2018 and has held it in 31 quarters since. 3,845 funds tracked by Wall St. Rank hold MRK as of Q2 2026.
- Fort Sheridan Advisors held 98,070 shares of Merck worth $12.6M as of Q2 2026.
- Fort Sheridan Advisors sold 541 Merck shares in Q2 2026, an estimated $63.3K.
- Merck made up 1.36% of Fort Sheridan Advisors's portfolio in Q2 2026, its #17 holding.
- Fort Sheridan Advisors first reported a position in Merck in Q4 2018 and has held it in 31 quarters since.
- 3,845 funds tracked by Wall St. Rank held Merck as of Q2 2026.
Based on Fort Sheridan Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.